Related Experiment Video
Updated: Jul 25, 2026
06:00
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Structure-based analysis of the effects of camptothecin on the activities of human topoisomerase I
1Department of Microbiology, Box 357242, University of Washington, Seattle, Washington 98195-7242, USA. champoux@u.washington.edu
Annals of the New York Academy of Sciences
|February 24, 2001
Summary
Camptothecin (CPT) targets type I topoisomerase, trapping it on DNA. This study explores the structural basis for CPT
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- The anticancer drug camptothecin (CPT) specifically targets type I topoisomerase.
- CPT functions by inhibiting the religation step of DNA cleavage, forming a covalent enzyme-DNA complex.
- CPT also inhibits plasmid DNA relaxation in vitro.
Purpose of the Study:
- To investigate the structural underpinnings of camptothecin's dual activities.
- To correlate these activities with the recently elucidated crystal structure of topoisomerase I bound to DNA.
Main Methods:
- Structural analysis based on the crystal structure of topoisomerase I-DNA complex.
- In vitro assays to assess DNA relaxation inhibition.
Main Results:
- The study explores the structural mechanisms behind CPT's topoisomerase poisoning.
- Structural insights into CPT's inhibition of plasmid DNA relaxation are provided.
Conclusions:
- The structural basis for camptothecin's anticancer activity is elucidated.
- Understanding these structural interactions can inform future drug development.
Related Concept Videos
02:02DNA Topoisomerases
Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...